Related references
Note: Only part of the references are listed.Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy
David Dora et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Detecting Liver Cancer Using Cell-Free DNA Fragmentomes
Zachariah H. Foda et al.
CANCER DISCOVERY (2023)
Comprehensive liquid biopsy analysis as a tool for the early detection of minimal residual disease in breast cancer
Dimitra Stergiopoulou et al.
SCIENTIFIC REPORTS (2023)
Advances in the Molecular Landscape of Lung Cancer Brain Metastasis
Vanessa G. P. Souza et al.
CANCERS (2023)
Early detection and prognosis prediction for colorectal cancer by circulating tumour DNA methylation haplotypes: A multicentre cohort study
Shaobo Mo et al.
ECLINICALMEDICINE (2023)
Liquid Biopsy and Immuno-Oncology for Advanced Nonsmall Cell Lung Cancer
Lea Sinoquet et al.
CLINICAL CHEMISTRY (2023)
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
Christopher Abbosh et al.
NATURE (2023)
A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer
Zoe June F. Assaf et al.
NATURE MEDICINE (2023)
Role of circulating-tumor DNA in the early-stage non-small cell lung carcinoma as a predictive biomarker
Saqib Raza Khan et al.
PATHOLOGY RESEARCH AND PRACTICE (2023)
Minimal Residual Disease Monitoring in Radically Treated Non-Small Cell Lung Cancer: Challenges and Future Directions
Hazel M. O'Sullivan et al.
ONCOTARGETS AND THERAPY (2023)
Liquid biopsy on the horizon in immunotherapy of non-small cell lung cancer: current status, challenges, and perspectives
Ying Yang et al.
CELL DEATH & DISEASE (2023)
Pleural fluid microbiota as a biomarker for malignancy and prognosis
Benjamin Kwok et al.
SCIENTIFIC REPORTS (2023)
Multi-omics integrated circulating cell-free DNA genomic signatures enhanced the diagnostic performance of early- cancer and minimal residual disease
Yun Li et al.
EBIOMEDICINE (2023)
Sequence-Based Platforms for Discovering Biomarkers in Liquid Biopsy of Non-Small-Cell Lung Cancer
Liam J. Brockley et al.
CANCERS (2023)
Current and future applications of liquid biopsy in non-small-cell lung cancer-a narrative review
Bartlomiej Tomasik et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2023)
A Preliminary Study on Microbiota Characteristics of Bronchoalveolar Lavage Fluid in Patients with Pulmonary Nodules Based on Metagenomic Next-Generation Sequencing
Qian Yuan et al.
BIOMEDICINES (2023)
Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer
Stefania Crucitta et al.
CLINICA CHIMICA ACTA (2023)
Biomarkers in the management of lung cancer: changing the practice of thoracic oncology
Bohuslav Melichar
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)
Liquid Biopsy Screening for Early Detection of Lung Cancer: Current State and Future Directions
William Zhu et al.
CLINICAL LUNG CANCER (2023)
Bacterial Infections and Cancer: Exploring This Association And Its Implications for Cancer Patients
Kafayat Yusuf et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients
J. Chen et al.
ANNALS OF ONCOLOGY (2022)
Perioperative circulating tumor DNA as a potential prognostic marker for operable stage I to IIIA non-small cell lung cancer
Ning Li et al.
CANCER (2022)
Perioperative ctDNA-Based Molecular Residual Disease Detection for Non-Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1)
Liang Xia et al.
CLINICAL CANCER RESEARCH (2022)
Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring
Wen Li et al.
MOLECULAR CANCER (2022)
Tumor-derived exosomes: Key players in non-small cell lung cancer metastasis and their implication for targeted therapy
Maryam Noor Rizwan et al.
MOLECULAR CARCINOGENESIS (2022)
Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer
D. Gale et al.
ANNALS OF ONCOLOGY (2022)
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?
Laura Bonanno et al.
BRITISH JOURNAL OF CANCER (2022)
Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer Patients
L. Y. Lois Choy et al.
CLINICAL CHEMISTRY (2022)
ALK-Fusion Transcripts Can Be Detected in Extracellular Vesicles (EVs) from Nonsmall Cell Lung Cancer Cell Lines and Patient Plasma: Toward EV-Based Noninvasive Testing
Estela Sanchez-Herrero et al.
CLINICAL CHEMISTRY (2022)
Evaluation of the TruSight Oncology 500 Assay for Routine Clinical Testing of Tumor Mutational Burden and Clinical Utility for Predicting Response to Pembrolizumab
Bo Wei et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2022)
Distinct bronchial microbiome precedes clinical diagnosis of lung cancer
Erin A. Marshall et al.
MOLECULAR CANCER (2022)
Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments
Saife N. Lone et al.
MOLECULAR CANCER (2022)
Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer
Hsiang-Ling Ho et al.
PLOS ONE (2022)
The impact of VEGF on cancer metastasis and systemic disease
Yunlong Yang et al.
SEMINARS IN CANCER BIOLOGY (2022)
The potential of liquid biopsy in the management of cancer patients
A. Markou et al.
SEMINARS IN CANCER BIOLOGY (2022)
Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients
Dongsheng Yue et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2022)
The utility of sputum supernatant as an alternative liquid biopsy specimen for next-generation sequencing-based somatic variation profiling
Ling Qin et al.
ANNALS OF TRANSLATIONAL MEDICINE (2022)
Cell-Free DNA Fragmentomics in Liquid Biopsy
Spencer C. Ding et al.
DIAGNOSTICS (2022)
Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer
E. Heitzer et al.
ESMO OPEN (2022)
The gut microbiome, immune check point inhibition and immune-related adverse events in non-small cell lung cancer
Philip Bredin et al.
CANCER AND METASTASIS REVIEWS (2022)
Tumor endothelial cell-derived extracellular vesicles contribute to tumor microenvironment remodeling
Jian Gao et al.
CELL COMMUNICATION AND SIGNALING (2022)
Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI-Treated Patients with EGFR-Mutant NSCLC (SWOG S1403)
Philip C. Mack et al.
CLINICAL CANCER RESEARCH (2022)
Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients
Florian Janke et al.
CLINICAL EPIGENETICS (2022)
Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II-IIIA NSCLC patients
Daan C. L. Vessies et al.
MOLECULAR ONCOLOGY (2022)
Onco-biome in pharmacotherapy for lung cancer: a narrative review
Akiko T. Tateishi et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2022)
Cerebrospinal fluid-derived circulating tumor DNA is more comprehensive than plasma in NSCLC patients with leptomeningeal metastases regardless of extracranial evolution
Hainan Yang et al.
HELIYON (2022)
Cancer type classification using plasma cell-free RNAs derived from human and microbes
Shanwen Chen et al.
ELIFE (2022)
Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study
Fangfang Shen et al.
FRONTIERS IN ONCOLOGY (2022)
Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis
Estela Sanchez-Herrero et al.
FRONTIERS IN ONCOLOGY (2022)
Polyadenylation ligation-mediated sequencing (PALM-Seq) characterizes cell-free coding and non-coding RNAs in human biofluids
Zhongzhen Liu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2022)
Liquid biopsy: current technology and clinical applications
Mina Nikanjam et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer
Siwei Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
The lung microbiome, peripheral gene expression, and recurrence-free survival after resection of stage II non-small cell lung cancer
Brandilyn A. Peters et al.
GENOME MEDICINE (2022)
Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer
Peilong Li et al.
CLINICAL EPIGENETICS (2022)
Bacterial biomarkers capable of identifying recurrence or metastasis carry disease severity information for lung cancer
Xuelian Yuan et al.
FRONTIERS IN MICROBIOLOGY (2022)
Exploring Gut Microbiome in Predicting the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer
Ben Liu et al.
CANCERS (2022)
Current challenges and best practices for cell-free long RNA biomarker discovery
Lluc Cabus et al.
BIOMARKER RESEARCH (2022)
Comprehensive characterization reveals sputum supernatant as a valuable alternative liquid biopsy for genome profiling in advanced non-small cell lung cancer
Xiaohong Xie et al.
RESPIRATORY RESEARCH (2022)
The Role of Serial Liquid Biopsy in the Management of Metastatic Non-Small Cell Lung Cancer (NSCLC)
Srikar Sama et al.
CLINICS AND PRACTICE (2022)
Opportunities for Early Cancer Detection: The Rise of ctDNA Methylation-Based Pan-Cancer Screening Technologies
Nicolas Constantin et al.
EPIGENOMES (2022)
Strategies for the successful implementation of plasma-based NSCLC genotyping in clinical practice
Charu Aggarwal et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
DNA methylation in lung cancer patients: Opening a window of life under precision medicine
Runzhang Liang et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer
Xiao-Rong Yang et al.
CLINICAL & EXPERIMENTAL METASTASIS (2021)
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform
Ana Gimenez-Capitan et al.
CLINICAL CHEMISTRY (2021)
Circulating microbiome DNA: An emerging paradigm for cancer liquid biopsy
Haiming Chen et al.
CANCER LETTERS (2021)
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
Khiem C. Lam et al.
CELL (2021)
Steps in metastasis: an updated review
Jamal Majidpoor et al.
MEDICAL ONCOLOGY (2021)
Liquid biopsy enters the clinic - implementation issues and future challenges
Michail Ignatiadis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk
Deguang Kong et al.
ONCOGENE (2021)
Progress of exosomes in the diagnosis and treatment of lung cancer
Kanghong Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Nanopore sequencing technology, bioinformatics and applications
Yunhao Wang et al.
NATURE BIOTECHNOLOGY (2021)
Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
Filippo Martignano et al.
MOLECULAR CANCER (2021)
Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis
Ming-Yue Li et al.
MOLECULAR CANCER (2021)
Liquid Biopsies: Applications for Cancer Diagnosis and Monitoring
Ivana Martins et al.
GENES (2021)
The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC
M. V. Verschueren et al.
SCIENTIFIC REPORTS (2021)
Lessons to learn from tumor-educated platelets
Harvey G. Roweth et al.
BLOOD (2021)
Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact
Natasha Honore et al.
CANCERS (2021)
Emerging Role of Extracellular Vesicles and Cellular Communication in Metastasis
Aisling Forder et al.
CELLS (2021)
Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
Yan Peng et al.
FRONTIERS IN ONCOLOGY (2021)
Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies
Y. M. Dennis Lo et al.
SCIENCE (2021)
Serum Exosomal miRNA Might Be a Novel Liquid Biopsy to Identify Leptomeningeal Metastasis in Non-Small Cell Lung Cancer
Qiuli Xu et al.
ONCOTARGETS AND THERAPY (2021)
Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC)
Biagio Ricciuti et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
Claudia Freitas et al.
FRONTIERS IN ONCOLOGY (2021)
What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology?-Considerations on pre-analytical aspects by the IFCC workgroup cfDNA
R. Danesi et al.
CLINICA CHIMICA ACTA (2021)
EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
Raju Kandimalla et al.
CLINICAL CANCER RESEARCH (2021)
Liquid Biopsy Hotspot Variant Assays: Analytical Validation for Application in Residual Disease Detection and Treatment Monitoring
Ariane Hallermayr et al.
CLINICAL CHEMISTRY (2021)
Tumor-associated exosomes promote lung cancer metastasis through multiple mechanisms
Chunyang Jiang et al.
MOLECULAR CANCER (2021)
Monitoring HOTTIP levels on extracellular vesicles for predicting recurrence in surgical non-small cell lung cancer patients
Han Bing et al.
TRANSLATIONAL ONCOLOGY (2021)
Exosomes and organ-specific metastasis
Lei Zhao et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments
Daniel Di Capua et al.
CANCERS (2021)
Clinical Application of Next-Generation Sequencing of Plasma Cell-Free DNA for Genotyping Untreated Advanced Non-Small Cell Lung Cancer
Maria Gabriela O. Fernandes et al.
CANCERS (2021)
Urine as a Source of Liquid Biopsy for Cancer
Masanori Oshi et al.
CANCERS (2021)
Exosomes in Lung Cancer: Actors and Heralds of Tumor Development
Amaia Sandua et al.
CANCERS (2021)
Liquid Biopsy for Disease Monitoring in Non-Small Cell Lung Cancer: The Link between Biology and the Clinic
Maria Gabriela O. Fernandes et al.
CELLS (2021)
ctDNA Predicts Overall Survival in Patients With NSCLC Treated With PD-L1 Blockade or With Chemotherapy
Wei Zou et al.
JCO PRECISION ONCOLOGY (2021)
Exosomal microRNAs in non-small cell lung cancer
Elena Durendez-Saez et al.
TRANSLATIONAL CANCER RESEARCH (2021)
Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLC
Michael L. Cheng et al.
JCO PRECISION ONCOLOGY (2021)
Genetic and non-genetic clonal diversity in cancer evolution
James R. M. Black et al.
NATURE REVIEWS CANCER (2021)
MS-Based Biomarker Discovery in Bronchoalveolar Lavage Fluid for Lung Cancer
Rune Matthiesen
PROTEOMICS CLINICAL APPLICATIONS (2020)
Lung Cancer 2020 Epidemiology, Etiology, and Prevention
Brett C. Bade et al.
CLINICS IN CHEST MEDICINE (2020)
Tumor-educated platelet as liquid biopsy in lung cancer patients
Lian Liu et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Current status and development of anti-PD-1/PD-L1 immunotherapy for lung cancer
Luyao Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Combined use of circulating tumor cells and salivary mRNA to detect non-small-cell lung cancer
Xianwen Gu et al.
MEDICINE (2020)
The biology, function, and biomedical applications of exosomes
Raghu Kalluri et al.
SCIENCE (2020)
Extracellular Vesicles in Non-Small-Cell Lung Cancer: Functional Role and Involvement in Resistance to Targeted Treatment and Immunotherapy
Luigi Pasini et al.
CANCERS (2020)
Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages
Nicolas Guibert et al.
EUROPEAN RESPIRATORY REVIEW (2020)
Interaction between microbiota and immunity in health and disease
Danping Zheng et al.
CELL RESEARCH (2020)
Plasma Long Non-Coding RNA RP11-438N5.3 as a Novel Biomarker for Non-Small Cell Lung Cancer
Qingjuan Chen et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Sputum supernatant as an alternative source for liquid biopsy in patients with advanced lung cancer.
Ting Guo et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib
Anna Buder et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M. C. Liu et al.
ANNALS OF ONCOLOGY (2020)
The Metastatic Cascade as the Basis for Liquid Biopsy Development
Zahra Eslami-S et al.
FRONTIERS IN ONCOLOGY (2020)
Development and validation of a preoperative noninvasive predictive model based on circular tumor DNA for lymph node metastasis in resectable non-small cell lung cancer
Rusi Zhang et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Next Generation Sequencing for Gene Fusion Analysis in Lung Cancer: A Literature Review
Rossella Bruno et al.
DIAGNOSTICS (2020)
Genomic Analysis of Circulating Tumor Cells at the Single-Cell Level
Shan Lu et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2020)
Extracellular Vesicles Are Key Regulators of Tumor Neovasculature
Naoya Kuriyama et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Analytical development of the RaDaR™ assay, a highly sensitive and specific assay for the monitoring of minimal residual disease
Giovanni Marsico et al.
CANCER RESEARCH (2020)
Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement Analysis
Yi Lee et al.
JCO PRECISION ONCOLOGY (2020)
Prospective Evaluation of Single Nucleotide Variants by Two Different Technologies in Paraffin Samples of Advanced Non-Small Cell Lung Cancer Patients
Elba Marin et al.
DIAGNOSTICS (2020)
Liquid Biopsies to Evaluate Immunogenicity of Gynecological/Breast Tumors: On the Way to Blood-Based Biomarkers for Immunotherapies
Corinna Keup et al.
BREAST CARE (2020)
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab
Scott V. Bratman et al.
NATURE CANCER (2020)
Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer
Nitin Roper et al.
CELL REPORTS MEDICINE (2020)
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT
Xina Zhang et al.
MOLECULAR CANCER (2019)
Neutrophils escort circulating tumour cells to enable cell cycle progression
Barbara Maria Szczerba et al.
NATURE (2019)
RNA sequencing and swarm intelligence-enhanced classification algorithm development for blood-based disease diagnostics using spliced blood platelet RNA
Myron G. Best et al.
NATURE PROTOCOLS (2019)
Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells
Zhe Su et al.
CLINICAL CANCER RESEARCH (2019)
Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer
Georgina Gonzalez-Avila et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Genome-wide cell-free DNA fragmentation in patients with cancer
Stephen Cristiano et al.
NATURE (2019)
Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor-Mutant Lung Cancer
Florian J. Fintelmann et al.
ONCOLOGIST (2019)
Potential Role of Exosomes in Cancer Metastasis
Wenjuan Tian et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis
Laura M. Doyle et al.
CELLS (2019)
MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer
Chunhua Wei et al.
AGING-US (2019)
A panel of DNA methylated markers predicts metastasis of pN0M0 gastric carcinoma: a prospective cohort study
Zhaojun Liu et al.
BRITISH JOURNAL OF CANCER (2019)
Early change in circulating tumor DNA as a potential predictor of response to chemotherapy in patients with metastatic colorectal cancer
Hiroki Osumi et al.
SCIENTIFIC REPORTS (2019)
DNA Methylation Cancer Biomarkers: Translation to the Clinic
Warwick J. Locke et al.
FRONTIERS IN GENETICS (2019)
Blood mRNA Measurement (NETest) for Neuroendocrine Tumor Diagnosis of Image-Negative Liver Metastatic Disease
Anna Malczewska et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer
Charu Aggarwal et al.
JAMA ONCOLOGY (2019)
Transfer of Extracellular Vesicle-Associated-RNAs Induces Drug Resistance in ALK-Translocated Lung Adenocarcinoma
Hoi-Hin Kwok et al.
CANCERS (2019)
Role of Matrix Metalloproteinases in Angiogenesis and Cancer
Saray Quintero-Fabian et al.
FRONTIERS IN ONCOLOGY (2019)
Extracellular vesicle-based EGFR genotyping in bronchoalveolar lavage fluid from treatment-naive non-small cell lung cancer patients
Jae Young Hur et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2019)
Next-generation sequencing in liquid biopsy: cancer screening and early detection
Ming Chen et al.
HUMAN GENOMICS (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification
L. Liu et al.
ANNALS OF ONCOLOGY (2018)
Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy
Y. S. Li et al.
ANNALS OF ONCOLOGY (2018)
Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types
Toshiyuki Ishiba et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
The potential predictive value of circulating immune cell ratio and tumor marker in atezolizumab treated advanced non-small cell lung cancer patients
Minglei Zhuo et al.
CANCER BIOMARKERS (2018)
Circulating cell-free nucleic acids: characteristics and applications
Ondrej Pos et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2018)
Leptomeningeal metastases in non-small-cell lung cancer
Haiying Cheng et al.
LANCET ONCOLOGY (2018)
Platelets Promote Metastasis via Binding Tumor CD97 Leading to Bidirectional Signaling that Coordinates Transendothelial Migration
Yvona Ward et al.
CELL REPORTS (2018)
The role of liquid biopsy in predicting post-operative recurrence of non-small cell lung cancer
Hengrui Liang et al.
JOURNAL OF THORACIC DISEASE (2018)
Analytical validation of the Signatera™ RUO assay, a highly sensitive patient-specific multiplex PCR NGS-based noninvasive cancer recurrence detection and therapy monitoring assay
Himanshu Sethi et al.
CANCER RESEARCH (2018)
Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA
Jong Sik Lee et al.
BMC CANCER (2018)
Identification of tumor-educated platelet biomarkers of non-small-cell lung cancer
Meiling Sheng et al.
ONCOTARGETS AND THERAPY (2018)
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
Maha Elazezy et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2018)
Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer
Qingyun Liu et al.
ONCOTARGET (2017)
Platelet-derived Extracellular Vesicles: An Emerging Therapeutic Approach
Shi-Cong Tao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Microfluidic isolation of platelet-covered circulating tumor cells
Xiaocheng Jiang et al.
LAB ON A CHIP (2017)
Integrating liquid biopsies into the management of cancer
Giulia Siravegna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Recurrence and Risk Factors for Relapse in Patients with Non-Small Cell Lung Cancer Treated by Surgery with Curative Intent
Cristiana Cruz et al.
ONCOLOGY (2017)
Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab
Salvatore Caponnetto et al.
ONCOLOGY (2017)
Circulating microRNA-422a is associated with lymphatic metastasis in lung cancer
Lina Wu et al.
ONCOTARGET (2017)
Liquid biopsy genotyping in lung cancer: ready for clinical utility?
Wei-Lun Huang et al.
ONCOTARGET (2017)
Exosomes from metastatic cancer cells transfer amoeboid phenotype to non-metastatic cells and increase endothelial permeability: their emerging role in tumor heterogeneity
Odessa Schillaci et al.
SCIENTIFIC REPORTS (2017)
Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer
Rui Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Extracellular Vesicles in Angiogenesis
Dilyana Todorova et al.
CIRCULATION RESEARCH (2017)
The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer
Jia Zhou et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan et al.
CELL (2017)
Progression and metastasis of lung cancer
Helmut H. Popper
CANCER AND METASTASIS REVIEWS (2016)
Cell-free DNA in maternal plasma and serum: A comparison of quantity, quality and tissue origin using genomic and epigenomic approaches
Felix C. K. Wong et al.
CLINICAL BIOCHEMISTRY (2016)
Exosomes and tumor-mediated immune suppression
Theresa L. Whiteside
JOURNAL OF CLINICAL INVESTIGATION (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Identifying Thoracic Malignancies Through Pleural Fluid Biomarkers A Predictive Multivariate Model
Jose M. Porcel et al.
MEDICINE (2016)
Haplotyping germline and cancer genomes with high-throughput linked-read sequencing
Grace X. Y. Zheng et al.
NATURE BIOTECHNOLOGY (2016)
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer
Justin F. Gainor et al.
CANCER DISCOVERY (2016)
Follow up analysis by exosomal miRNAs in EGFR mutated non-small cell lung cancer (NSCLC) patients during osimertinib (AZD9291) treatment: A potential prognostic biomarker tool.
Marco Giallombardo et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics community
Miten Jain et al.
GENOME BIOLOGY (2016)
Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study
Mikolaj P. Zaborowski et al.
BIOSCIENCE (2015)
Non-random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation
Maxim Ivanov et al.
BMC GENOMICS (2015)
RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics
Myron G. Best et al.
CANCER CELL (2015)
Tumour exosome integrins determine organotropic metastasis
Ayuko Hoshino et al.
NATURE (2015)
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Bruno Costa-Silva et al.
NATURE CELL BIOLOGY (2015)
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M
Kenneth S. Thress et al.
NATURE MEDICINE (2015)
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
Leticia De Mattos-Arruda et al.
NATURE COMMUNICATIONS (2015)
Highly sensitive and quantitative evaluation of the EGFR T790M mutation by nanofluidic digital PCR
Eiji Iwama et al.
ONCOTARGET (2015)
Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer
Liqin Shen et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Biological properties of extracellular vesicles and their physiological functions
Maria Yanez-Mo et al.
JOURNAL OF EXTRACELLULAR VESICLES (2015)
Specific organ metastases and survival in metastatic non-small-cell lung cancer
Tomohiro Tamura et al.
MOLECULAR AND CLINICAL ONCOLOGY (2015)
Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification
Alison S. Devonshire et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2014)
Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non-Small Cell Lung Cancer
Feiran Lou et al.
ANNALS OF THORACIC SURGERY (2014)
Serum biomarkers for assessing histology and outcomes in patients with metastatic lung cancer
Emil Lou et al.
CANCER BIOMARKERS (2014)
The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets
Steven L. Wood et al.
CANCER TREATMENT REVIEWS (2014)
Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002
Sebastien Couraud et al.
CLINICAL CANCER RESEARCH (2014)
Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: A prospective multicenter study in a real-world setting (GFPC study 12-01)
Christos Chouaid et al.
LUNG CANCER (2014)
Metastatic sites and survival in lung cancer
M. Riihimaeki et al.
LUNG CANCER (2014)
Time-Varying Pattern of Postoperative Recurrence Risk of Early-Stage (T1a-T2bN0M0) Non-Small Cell Lung Cancer (NSCLC): Results of a Single-Center Study of 994 Chinese Patients
Jian-fei Zhu et al.
PLOS ONE (2014)
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naive non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
A. Inoue et al.
ANNALS OF ONCOLOGY (2013)
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
Helena A. Yu et al.
CLINICAL CANCER RESEARCH (2013)
Liquid biopsy: monitoring cancer-genetics in the blood
Emily Crowley et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients
Xiaohui Ni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell et al.
LANCET ONCOLOGY (2012)
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Hector Peinado et al.
NATURE MEDICINE (2012)
Specific organ metastases and survival in small cell lung cancer
Kensuke Nakazawa et al.
ONCOLOGY LETTERS (2012)
The Initial Hours of Metastasis: The Importance of Cooperative Host-Tumor Cell Interactions during Hematogenous Dissemination
Myriam Labelle et al.
CANCER DISCOVERY (2012)
Lung Cancer Signatures in Plasma Based on Proteome Profiling of Mouse Tumor Models
Ayumu Taguchi et al.
CANCER CELL (2011)
Recovering circulating extracellular or cell-free RNA from bodily fluids
Georgios Tzimagiorgis et al.
CANCER EPIDEMIOLOGY (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
The Detection of Chromosomal Aneusomy by Fluorescence In situ Hybridization in Sputum Predicts Lung Cancer Incidence
Marileila Varella-Garcia et al.
CANCER PREVENTION RESEARCH (2010)
Significant Downregulation of Platelet Gene Expression in Metastatic Lung Cancer
David C. Calverley et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2010)
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
Tetsuya Mitsudomi et al.
LANCET ONCOLOGY (2010)
Real-Time DNA Sequencing from Single Polymerase Molecules
John Eid et al.
SCIENCE (2009)
Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer
Martin Frueh et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
National survey of non-small cell lung cancer in the United States: Epidemiology, pathology and patterns of care
Alex G. Little et al.
LUNG CANCER (2007)
Tumor-released microvesicles as vehicles of immunosuppression
Roberta Valenti et al.
CANCER RESEARCH (2007)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
Matrix metalloproteinases and tumor metastasis
EI Deryugina et al.
CANCER AND METASTASIS REVIEWS (2006)
Determination of allele frequency in pooled DNA:: comparison of three PCR-based methods
S Wilkening et al.
BIOTECHNIQUES (2005)
Molecular biology of breast cancer metastasis - Clinical implications of experimental studies on metastatic inefficiency
AF Chambers et al.
BREAST CANCER RESEARCH (2000)
Role of ctDNA for the detection of minimal residual disease in resected non-small cell lung cancer: a systematic review
Michela Verze et al.
TRANSLATIONAL LUNG CANCER RESEARCH